What is Quantum X Labs Inc's earnings per share (EPS)?

Quantum X Labs Inc (QXL) reported diluted earnings per share of $2.28 for fiscal year 2025. This represents a -15.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Quantum X Labs Inc Financials

QXL

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Quantum X Labs Inc (QXL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI QXL FY2025 2026-05-14

Asset shrinkage and thin liquidity now define a business whose losses are eroding balance-sheet capacity faster than debt is accumulating.

In the last year, total assets fell from $22.0M to $10.8M, so the company is becoming smaller while still carrying a meaningful legacy asset base. With goodwill-heavy assets at $6.4M and cash at only $1.0M, the reported equity base looks less able to absorb strain or fund operations than the headline asset total suggests.

Earnings quality is weak in an unusual way: the latest year showed a $19.3M net loss but only -$2.8M of operating cash flow. That pattern usually means non-cash charges dominated the income statement, so the cash drain is real but the business is also absorbing the delayed cost of earlier investments.

Debt is not the main pressure point, with long-term borrowings at just $586K. The tighter issue is working-capital strain: the current ratio slipped from 0.6x to 0.4x, which means near-term obligations are getting harder to cover even as the company carries little structural leverage.

Financial Health Signals

Financial Profile 24/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Quantum X Labs Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

100

Quantum X Labs Inc carries a low D/E ratio of 0.12, meaning only $0.12 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Quantum X Labs Inc's current ratio of 0.41 is below the typical benchmark, resulting in a score of 2/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Returns

Quantum X Labs Inc generates a -386.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -208.8% the prior year.

Piotroski F-Score Weak

2/9

Quantum X Labs Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality

0.14x

For every $1 of reported earnings, Quantum X Labs Inc generates $0.14 in operating cash flow (-$2.8M OCF vs -$19.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-34.7x

Quantum X Labs Inc earns $-34.7 in operating income for every $1 of interest expense (-$2.2M vs $63K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

-$1.3M

YoY-5466.7%

Quantum X Labs Inc's EBITDA was -$1.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 5466.7% from the prior year.

Net Income

-$19.3M

YoY-60.0%

Quantum X Labs Inc reported -$19.3M in net income in fiscal year 2025. This represents a decrease of 60.0% from the prior year.

EPS (Diluted)

$2.28

YoY-15.2%

Quantum X Labs Inc earned $2.28 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 15.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$1.0M

YoY+4141.7%

5Y CAGR-21.2%

10Y CAGR+24.3%

Quantum X Labs Inc held $1.0M in cash against $586K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

11M

YoY-49.6%

Quantum X Labs Inc had 11M shares outstanding in fiscal year 2025. This represents a decrease of 49.6% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-386.6%

YoY-177.7pp

5Y CAGR-404.1pp

Quantum X Labs Inc's ROE was -386.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 177.7 percentage points from the prior year.

Capital Allocation

R&D Spending

$69K

YoY-91.7%

5Y CAGR-52.1%

Quantum X Labs Inc invested $69K in research and development in fiscal year 2025. This represents a decrease of 91.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

QXL Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	$26.9M-66.2%	$79.6M-17.6%	$96.6M+113.6%	$45.2M+18.6%	$38.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	$5K
Gross Profit	N/A	N/A	N/A	N/A	$41K-54.9%	$91K
R&D Expenses	$69K-91.7%	$830K-71.3%	$2.9M-11.1%	$3.3M+37.4%	$2.4M-13.5%	$2.7M
SG&A Expenses	$1.6M-12.3%	$1.9M-35.6%	$2.9M+33.4%	$2.2M+55.9%	$1.4M-20.1%	$1.7M
Operating Income	-$2.2M-160.9%	-$837K+88.8%	-$7.5M-374.1%	$2.7M+403.9%	$541K-72.3%	$2.0M
Interest Expense	$63K-60.6%	$160K+83.9%	$87K-39.2%	$143K	N/A	N/A
Income Tax	-$39K-129.8%	$131K+298.5%	-$66K-143.1%	$153K+70.0%	$90K-50.3%	$181K
Net Income	-$19.3M-60.0%	-$12.1M-64.6%	-$7.3M-26253.6%	$28K-90.7%	$300K-87.1%	$2.3M
EPS (Diluted)	$2.28-15.2%	$2.69	$1.97	$0.00-100.0%	$0.02-87.5%	$0.16

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$343K	N/A	$2.7M+19.1%	$2.3M-16.5%	$2.7M-17.8%	$3.3M-47.1%	$6.3M-14.3%	$7.3M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$16K	N/A	$115K-8.0%	$125K+681.3%	$16K+102.1%	-$770K-327.8%	$338K-36.5%	$532K
SG&A Expenses	$500K	N/A	$619K+7.5%	$576K+192.4%	$197K+69.8%	$116K-73.3%	$435K-32.7%	$646K
Operating Income	-$550K	N/A	-$3.6M+26.2%	-$4.9M-8847.3%	-$55K-100.8%	$6.6M+824.0%	-$906K+83.5%	-$5.5M
Interest Expense	$260K	N/A	$81K-33.6%	$122K+221.1%	$38K+117.4%	-$219K-254.2%	$142K-28.3%	$198K
Income Tax	-$16K	N/A	-$348K-178.4%	-$125K-397.6%	$42K-80.3%	$213K+461.0%	-$59K-145.8%	-$24K
Net Income	-$605K	N/A	-$3.4M+70.9%	-$11.7M-217.8%	-$3.7M-11.6%	-$3.3M-457.1%	-$590K+91.8%	-$7.2M
EPS (Diluted)	$0.05	N/A	$0.32-80.1%	$1.61+136.8%	$0.68	N/A	$0.12-93.7%	$1.91

QXL Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$10.8M-51.0%	$22.0M-49.2%	$43.3M-32.0%	$63.7M+24.3%	$51.3M+116.0%	$23.7M
Current Assets	$1.7M-78.7%	$7.8M-56.5%	$17.8M-40.3%	$29.8M+2.0%	$29.2M+75.9%	$16.6M
Cash & Equivalents	$1.0M+4141.7%	$24K-98.6%	$1.8M-57.7%	$4.2M-19.4%	$5.2M+55.7%	$3.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$315K-43.4%	$557K-95.1%	$11.4M-45.8%	$20.9M+27.6%	$16.4M+162.6%	$6.3M
Goodwill	$6.4M+490.2%	$1.1M-91.2%	$12.3M-29.4%	$17.4M+39.1%	$12.5M+330.2%	$2.9M
Total Liabilities	$5.8M-64.4%	$16.2M-43.1%	$28.5M-31.7%	$41.7M+11.0%	$37.5M+258.8%	$10.5M
Current Liabilities	$4.1M-68.6%	$12.9M-34.6%	$19.8M-30.7%	$28.5M+6.5%	$26.8M+184.0%	$9.4M
Long-Term Debt	$586K+18.1%	$496K-83.8%	$3.1M+6.4%	$2.9M-32.5%	$4.3M	N/A
Total Equity	$5.0M-13.6%	$5.8M-61.1%	$14.8M-32.7%	$22.0M+60.6%	$13.7M+3.3%	$13.3M
Retained Earnings	-$46.0M-102.7%	-$22.7M-113.1%	-$10.7M-219.4%	-$3.3M-41.1%	-$2.4M+11.3%	-$2.7M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$27.7M+157.6%	$10.8M-36.3%	$16.9M-16.0%	$20.1M-23.9%	$26.4M+20.2%	$22.0M-28.7%	$30.8M+2.6%	$30.0M
Current Assets	$2.9M+75.2%	$1.7M-59.7%	$4.1M-1.0%	$4.1M-36.4%	$6.5M-16.0%	$7.8M-39.9%	$12.9M+13.5%	$11.4M
Cash & Equivalents	$1.8M+76.1%	$1.0M-53.0%	$2.2M+8.9%	$2.0M+998.3%	$181K+654.2%	$24K-98.3%	$1.4M+130.7%	$609K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$355K+12.7%	$315K-76.3%	$1.3M+26.5%	$1.0M+1.2%	$1.0M+86.2%	$557K-90.9%	$6.1M+0.3%	$6.1M
Goodwill	$20.7M+224.1%	$6.4M+3.0%	$6.2M-5.3%	$6.6M-32.5%	$9.7M+796.0%	$1.1M-85.6%	$7.5M0.0%	$7.5M
Total Liabilities	$6.1M+5.8%	$5.8M-49.1%	$11.3M-27.3%	$15.6M-18.7%	$19.1M+18.2%	$16.2M-25.6%	$21.8M-5.1%	$22.9M
Current Liabilities	$4.2M+4.4%	$4.1M-52.5%	$8.6M-32.4%	$12.7M-17.6%	$15.4M+18.8%	$12.9M-23.6%	$16.9M+9.2%	$15.5M
Long-Term Debt	$390K-33.4%	$586K-25.0%	$781K	N/A	N/A	$496K-54.1%	$1.1M-35.4%	$1.7M
Total Equity	$21.6M+333.1%	$5.0M-10.2%	$5.6M+22.8%	$4.5M-37.7%	$7.3M+25.8%	$5.8M-36.2%	$9.0M+27.9%	$7.1M
Retained Earnings	-$46.7M-1.3%	-$46.0M-1.2%	-$45.5M-8.1%	-$42.1M-59.5%	-$26.4M-16.1%	-$22.7M-16.9%	-$19.4M-3.1%	-$18.8M

QXL Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$2.8M-279.5%	$1.5M+65.2%	$934K-71.1%	$3.2M-25.9%	$4.4M+47.7%	$3.0M
Capital Expenditures	N/A	$1K-93.8%	$16K-72.4%	$58K-81.4%	$311K+465.5%	$55K
Free Cash Flow	N/A	$1.5M+68.0%	$918K-71.1%	$3.2M-21.6%	$4.1M+39.8%	$2.9M
Investing Cash Flow	N/A	-$1K+93.8%	-$16K+78.4%	-$74K+99.3%	-$10.8M-4749.1%	-$222K
Financing Cash Flow	N/A	-$2.8M+17.6%	-$3.4M+20.1%	-$4.2M-151.0%	$8.3M+758.5%	-$1.3M
Dividends Paid	N/A	N/A	$130K+78.1%	$73K	N/A	$386K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$604K-177.1%	-$218K+87.3%	-$1.7M-301.6%	-$427K-4.4%	-$409K+8.5%	-$447K-183.7%	$534K-60.4%	$1.3M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	$0	$0-100.0%	$12K	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	$1.9M-18.0%	$2.3M+5317.8%	-$45K+85.8%	-$317K-221.0%	$262K+112.7%	-$2.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

QXL Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	0.1%-0.1pp	0.2%
Operating Margin	N/A	-3.1%+6.3pp	-9.4%-12.2pp	2.8%+1.6pp	1.2%-3.9pp	5.1%
Net Margin	N/A	-44.7%-35.5pp	-9.2%-9.2pp	0.0%-0.6pp	0.7%-5.5pp	6.1%
Return on Equity	-386.6%-177.7pp	-208.8%-159.4pp	-49.4%-49.5pp	0.1%-2.1pp	2.2%-15.4pp	17.5%
Return on Assets	-179.3%-124.4pp	-54.9%-37.9pp	-16.9%-17.0pp	0.0%-0.5pp	0.6%-9.2pp	9.8%
Current Ratio	0.41-0.2	0.60-0.3	0.90-0.1	1.05-0.0	1.09-0.7	1.76
Debt-to-Equity	0.12+0.0	0.09-0.1	0.21+0.1	0.13-0.2	0.31-0.5	0.79
FCF Margin	N/A	5.7%+4.6pp	1.1%-2.1pp	3.3%-5.7pp	9.0%+1.4pp	7.6%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-160.3%	N/A	-133.7%+82.0pp	-215.7%-213.7pp	-2.0%-199.3pp	197.3%+211.7pp	-14.4%+60.3pp	-74.7%
Net Margin	-176.4%	N/A	-124.9%+386.2pp	-511.1%-376.9pp	-134.2%-35.4pp	-98.9%-89.5pp	-9.4%+88.5pp	-97.9%
Return on Equity	-2.8%	N/A	-61.1%+196.7pp	-257.8%-207.2pp	-50.5%+6.4pp	-57.0%-50.4pp	-6.5%+95.0pp	-101.5%
Return on Assets	-2.2%	N/A	-20.1%+37.9pp	-58.0%-44.1pp	-13.9%+1.1pp	-15.0%-13.0pp	-1.9%+22.0pp	-23.9%
Current Ratio	0.68+0.3	0.41-0.1	0.48+0.2	0.33-0.1	0.42-0.2	0.60-0.2	0.76+0.0	0.73
Debt-to-Equity	0.02-0.1	0.12-0.0	0.14-3.3	3.44+0.8	2.64+2.6	0.09-0.0	0.12-0.1	0.24
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: The current ratio is below 1.0 (0.41), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Is Quantum X Labs Inc profitable?

No, Quantum X Labs Inc (QXL) reported a net income of -$19.3M in fiscal year 2025.

What is Quantum X Labs Inc's EBITDA?

Quantum X Labs Inc (QXL) had EBITDA of -$1.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Quantum X Labs Inc have?

As of fiscal year 2025, Quantum X Labs Inc (QXL) had $1.0M in cash and equivalents against $586K in long-term debt.

What is Quantum X Labs Inc's return on equity (ROE)?

Quantum X Labs Inc (QXL) has a return on equity of -386.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Quantum X Labs Inc's operating cash flow?

Quantum X Labs Inc (QXL) generated -$2.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Quantum X Labs Inc's total assets?

Quantum X Labs Inc (QXL) had $10.8M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Quantum X Labs Inc spend on research and development?

Quantum X Labs Inc (QXL) invested $69K in research and development during fiscal year 2025.

How many shares does Quantum X Labs Inc have outstanding?

Quantum X Labs Inc (QXL) had 11M shares outstanding as of fiscal year 2025.

What is Quantum X Labs Inc's current ratio?

Quantum X Labs Inc (QXL) had a current ratio of 0.41 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Quantum X Labs Inc's debt-to-equity ratio?

Quantum X Labs Inc (QXL) had a debt-to-equity ratio of 0.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Quantum X Labs Inc's return on assets (ROA)?

Quantum X Labs Inc (QXL) had a return on assets of -179.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Quantum X Labs Inc's cash runway?

Based on fiscal year 2025 data, Quantum X Labs Inc (QXL) had $1.0M in cash against an annual operating cash burn of $2.8M. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Quantum X Labs Inc's Piotroski F-Score?

Quantum X Labs Inc (QXL) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Quantum X Labs Inc's earnings high quality?

Quantum X Labs Inc (QXL) has an earnings quality ratio of 0.14x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Quantum X Labs Inc cover its interest payments?

Quantum X Labs Inc (QXL) has an interest coverage ratio of -34.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Quantum X Labs Inc?

Quantum X Labs Inc (QXL) scores 24 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.